Objectives: This article aims to comprehensively address and discuss the thresholds for implant removal in cases of severe peri-implantitis. Material and Methods: Electronic databases were searched comprehensively, electronically, and manually. Studies focusing on criteria for explantation of dental implants were included and reviewed comprehensively. Based on the latest evidence, explanation thresholds were proposed. Moreover, the included studies were evaluated and summarized. Results: Current guidelines for implant removal are primarily based on expert opinions rather than actual data. Standardized data encompassing the extent of peri-implant bone loss for assessing treatment outcomes after surgical intervention for peri-implantitis is scarce. Nevertheless, newly available data confirms a poor prognosis for implants with more than 50% bone loss. This supports the recommendation for implant removal in cases of more than 50% bone loss due to peri-implantitis. Implant mobility resulting from the total loss of osseointegration necessitates the removal of the implant. While probing depth provides information about disease severity, it should not be used as the sole diagnostic tool. In the decision-making process for treatment or explantation, factors such as the number of affected implants, the implant's position within the bony housing, intraosseous defect morphology, type of implant restoration, and patient characteristics should be considered. Conclusion: The removal of severely compromised dental implants with peri-implantitis and bone loss exceeding 50% is supported. Moreover, factors related to the restoration, the implant itself, and the patient must be considered when deciding whether to remove or salvage a compromised implant. Clinical Relevance: Clear clinical guidelines for explanting dental implants in cases of severe peri-implantitis need to be included. This poses significant challenges to clinicians when determining whether to explant or treat dental implants compromised by substantial bone loss. MeSH Terms: Dental implants, peri-implantitis, prognosis, implant removal, alveolar bone loss.

Download full-text PDF

Source
http://dx.doi.org/10.1563/aaid-joi-D-24-00098DOI Listing

Publication Analysis

Top Keywords

bone loss
24
implant removal
20
dental implants
20
implant
9
removal cases
8
cases severe
8
severe peri-implantitis
8
50% bone
8
implants peri-implantitis
8
removal
7

Similar Publications

Objective: To investigate the effects of Zexie decoction on vestibular and auditory function in guinea pigs with endolymphatic hydrolysis induced by desmopressin. Methods: Sixty guinea pigs were randomly and evenly divided into four groups, each group has 15 guinea pigs: normal control group, DDAVP group, DDAVP modeling combined with Zexie Decoction group, and DDAVP combined with Double Zexie group. At 7 and 14 days, bone-conducted cervical vestibular evoked myogenic potential tests, auditory brainstem responses, and distortion-product otoacoustic emissions were conducted on each group of guinea pigs to evaluate their vestibular and auditory function quantitatively.

View Article and Find Full Text PDF

Autophagy: regulating the seesaw of bone-fat balance.

Front Cell Dev Biol

February 2025

Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, School and Hospital of Stomatology, Jilin University, Changchun, China.

The interrelationship between bone and fat can be described as a seesaw in bone homeostasis, in which both osteogenesis and adipogenesis occur in a delicate balance. Osteoblasts and adipocytes share a common origin and play key roles in osteogenesis and adipogenesis. Bone-fat balance indicates osteogenesis and adipogenesis keeps a balance for concordant distribution of trabecular bone and bone marrow adipose tissue in bone, thereby leading to the balance between bone metabolism and lipid metabolism.

View Article and Find Full Text PDF

Specnuezhenide Alleviates Senile Osteoporosis by Activating TGR5/FXR Signaling in Bone Marrow Mesenchymal Stem Cells and RANKL-Induced Osteoclasts.

Drug Des Devel Ther

March 2025

Department of Medicine, Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang, People's Republic of China.

Background: Specnuezhenide (SPN) is an iridoid glycoside isolated from , an herb prescribed for the treatment of senile osteoporosis. However, the direct role of SPN on bone metabolism remains unclear. In this study, the effects of SPN on d-galactose (d-gal)-induced mice, bone marrow mesenchymal stem cells (BMSCs), and nuclear factor-κB ligand-induced osteoclasts were examined.

View Article and Find Full Text PDF

A 55-year-old female patient affected by an EGFR mutant NSCLC with multiple lytic bone metastases and two prior pathological fractures, undergoing treatment with osimertinib and denosumab, participated in a 9-month physical exercise program. The exercise program was performed twice a week and consisted of aerobic and strength training. Aerobic training was composed of moderate-intensity continuous training for the first 3 months and then high-intensity interval training.

View Article and Find Full Text PDF

An eight-year-old female, known to have sensorineural hearing loss due to inner ear anomalies, presented with a history of recurrent attacks of right acute otitis media complicated by bacterial meningitis. Temporal bone computed tomography showed right middle ear and mastoid effusion without bony dehiscence or erosion, with features of common cavity inner ear anomaly on the right side. Given the patient's inner ear malformation, cerebrospinal fluid (CSF) otorrhea was suspected.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!